Changes of acetylcholinesterase activity after long-term exposure to sarin vapors in rats

Human and Experimental Toxicology

Volumn 24, Issue 7, 2005, Pages 363-367

  Bartosova Sevelova, Lucie ^a   Bajgar, J ^a  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

Acetylcholinesterase; Brain parts; Inhalation; Long term exposure; Rat; Sarin

Indexed keywords

ACETYLCHOLINESTERASE; SARIN;

ANIMAL EXPERIMENT; ARTICLE; BASAL GANGLION; CHOLINESTERASE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CONVULSION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; FRONTAL CORTEX; HYPERSALIVATION; INHALATION; LONG TERM EXPOSURE; MEDULLA OBLONGATA; NONHUMAN; PONS; PRIORITY JOURNAL; RAT;

ACETYLCHOLINESTERASE; ANIMALS; BRAIN; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INHALATION EXPOSURE; RATS; RATS, WISTAR; SARIN; SEIZURES; SIALORRHEA;

ANIMALIA;

EID: 23744475047     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327105ht539oa     Document Type: Article

References (27)

1. Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 2004; 38: 151-216.
2. Marrs TC. Organophosphate poisoning. Pharmacol Therapeut 1993; 58: 51-66.
3. Nozaki H, Hori S, Shinozawa Y, Fujishima S, Takuma K, Sagoh M, Kimura H, Ohki T, Suzuki M, Aikawa N. Secondary exposure of medical staff to sarin vapor in the emergency room. Intensive Care Med 1995; 21: 1032-35.
4. Croddy E. Urban terrorism - chemical warfare in Japan. Jane's Intell Rev 1995; 7: 520-23.
5. Nakajima T, Sato S, Morita H, Yanagisawa N. Sarin poisoning of a rescue team in the Matsumoto incident in Japan. Occup Environ Med 1997; 54: 697-701.
6. Kassa J, Koupilová M, Vachek J. The influence of low-level sarin inhalation exposure on spatial memory in rats. Pharmacol Biochem Behav 2001; 70: 175-79.
7. Kassa J, Krocova Z, Sevelova L, Sheshko V, Kasalova I, Neubauerova V. Low-level sarin-induced alteration of immune system reaction in inbred BALB/c mice. Toxicology 2003; 187: 195-203.
8. Van Helden HP, Trap HC, Oostdijk JP, Kuijpers WC, Langenberg JP, Benschop HP. Long-term, low-level exposure of guinea pigs and marmosets to sarin vapor in air: lowest observable effect level. Toxicol Appl Pharmacol 2003; 189: 170-79.
9. Benschop HP, De Jong LPA, Langenberg JP. Enzymes of the cholinesterase family. Plenum: New York, 1995.
10. Mioduszewski R, Manthei J, Burnett D, Gaviola B, Muse W, Thomson S, Sommerville D, Crosier R. Interaction of exposure concentration and duration in determining acute toxic effects of sarin vapor in rats. Toxicol Sci 2002; 66: 176-84.
11. Sterri SH, Kloster O, Valdal G. Reduction of blood cholinesterase activities following administration of soman by different routes in guinea-pigs. Acta Pharmacol Toxicol 1982; 50: 326-31.
12. Matoušek J. Health and environmental risks associated with the destruction of chemical weapons. NATO - Russia Advanced Research Workshop Ecological Risks Associated with the Destruction of Chemical Weapons, 22-26.10.2003, Lüneburg.
13. Śevelová L, Vachek J, Bajgar J. Inhalation apparatus for generating sarin and soman toxic vapors. Acta Medica (Hradec Králové) 2003; 46: 157-61.
14. Ellman GL, Courtney DK, Andres V, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88-95.
15. Midtling JE, Barnett PG, Coye MJ, Velasco AR, Romero P, Clements CL, O'Malley MA, Tobin MW, Rose T, Monosson IH. Clinical management of field worker organophosphate poisoning. West J Med 1985; 142: 514-18.
16. Sullivan JB. Immunological alterations and chemical exposure. J Toxicol Clin Toxicol 1989; 27: 311-43.
17. Sidell RF. Chemical warfare agents. San Diego, CA: Academic Press Inc., 1992.
18. Spruit HE, Langenberg JP, Trap HC, van der Wiel HJ, Helmich RB, van Helden HP, Benschop HP. Intravenous and inhalation toxicokinetics of sarin stereoisomers in atropinized guinea pigs. Toxicol Appl Pharmacol 2000; 169: 249-54.
19. Benschop HP, Trap HC, Spruit HE, Van Der Wiel HJ, Langenberg JP, De Jong LP. Low level nose-only exposure to the nerve agent soman: toxicokinetics of soman stereoisomers and cholinesterase inhibition in atropinized guinea pigs. Toxicol Appl Pharmacol 1998; 153: 179-85.
20. Ecobichon DJ, Comeau AM. Pseudocholinesterases of mammalian plasma: physicochemical properties and organophosphate inhibition in eleven species. Toxicol Appl Pharmacol 1973; 24: 92-100.
21. Bajgar J. The influence of inhibitors and other factors on cholinesterases. Acta Medico Hradci Kralove 1991; 34: 5-77.
22. Clement JG. Importance of aliesterase as a detoxification mechanism for soman (Pinacolyl methylphosphonofluoridate) in mice. Biochem Pharmacol 1984; 33: 3807-11.
23. Grubic Z, Sket D, Brzin M. Iso-OMPA-induced potentiation of soman toxicity in rat correlates with the inhibition of plasma carboxylesterases. Arch Toxicol 1988; 62: 398-99.
24. Kassa J, Koupilova M, Vachek J. Long-term effects of low-level sarin inhalation exposure on the spatial memory of rats in a T-maze. Acta Medica (Hradec Kralove) 2001; 44: 93-96.
25. Kassa J, Pecka M, Tichy M, Bajgar J, Koupilova M, Herink J, Krocova Z. Toxic effects of sarin in rats at three months following single or repeated low-level inhalation exposure. Pharmacol Toxicol 2001; 88: 209-12.
26. Gupta RC, Patterson GT, Dettbarn WD. Comparison of cholinergic and neuromuscular toxicity following acute exposure to sarin and VX in rat. Fundam Appl Toxicol 16: 449-58.
27. Bajgar J. Biological monitoring of exposure to nerve agents. Br J Ind Med 1992; 49: 648-53.